Cerus Corp.
Cerus Corp. logo
CERS

Cerus Corp. (CERS)

$5.683.65%

  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$5.415
Day's Range
$5.75
$4.35
52-Week Range
$8.06
1 month return9.16%
3 month return2.24%
1 year return6.41%
5 year return142.48%

Company Information

Cerus Corporation is dedicated solely to safeguarding the world's blood supply and aims to become the preeminent global blood products company. Headquartered in Concord, California, the company develops and supplies vital technologies and pathogen-protected blood components to blood centers, hospitals, and ultimately patients who rely on safe blood. The INTERCEPT Blood System for platelets and plasma is available globally and remains the only pathogen reduction system with both CE mark and FDA approval for these two blood components. The INTERCEPT red blood cell system is under regulatory review in Europe, and in late-stage clinical development in the US. Also in the US, the INTERCEPT Blood System for Cryoprecipitation is approved for production of Pathogen Reduced Cryoprecipitated Fibrinogen Complex, a therapeutic product for the treatment and control of bleeding, including massive hemorrhage, associated with fibrinogen deficiency.
OrganizationCerus Corp.
CEOWilliam Greenman
IndustryHealth Technology

Analyst Recommendation

based on 11 analysts ratings

Buy
90%
Buy
9%
Hold
0%
Sell

Based on 11 Wall street analysts offering stock ratings for Cerus Corp.(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 91.61%

Current

$5.48

Target

$10.5

Recommendation Trend

Based on 11 analyst

Current1M Ago3M Ago
Buy
10
10
10
Hold
1
1
1
Sell
0
0
0
Consensus
BUY
BUY
BUY

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization
828.8M
Book Value
0.49
Dividend Share
0.0
Dividend Yield
0.0
Earnings Share
-0.32
PEG Ratio
0.0
Wall Street Target Price
9.4

Valuation

Trailing PE0.0
Forward PE0.0
Price/Sales (ttm)
6.33
Price/Book (mrq)
9.05
Enterprise Value
724.3M
Enterprise Value/Revenue
4.54
Enterprise Value/Ebitda
0.0

Technicals

Beta
1.17
50 Day MA
5.32
200 Day MA
5.97

Institutional Holdings

ARK Investment Management LLC

9.17%

Baker Bros Advisors LP

7.75%

BlackRock Inc

6.9%

Nikko Asset Management Americas Inc

6.52%

Sumitomo Mitsui Trust Holdings Inc

6.01%

PRIMECAP Management Company

5.39%

Discover more

Frequently Asked Questions

What is Cerus Corp. share price today?

Can Indians buy Cerus Corp. shares?

How can I buy Cerus Corp. shares from India?

Can Fractional shares of Cerus Corp. be purchased?

What are the documents required to start investing in Cerus Corp. stocks?

What are today’s High and Low prices of Cerus Corp.?

What are today’s traded volumes of Cerus Corp.?

What is today’s market capitalisation of Cerus Corp.?

What is the 52 Week High and Low Range of Cerus Corp.?

How much percentage Cerus Corp. is down from its 52 Week High?

How much percentage Cerus Corp. is up from its 52 Week low?

What are the historical returns of Cerus Corp.?

Who is the Chief Executive Officer (CEO) of Cerus Corp.?